What are the risk factors for intestinal transplant rejection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Risk factors for intestinal transplant rejection include immunological factors, technical and surgical complications, patient-related factors, and infections, which can be managed with personalized immunosuppression protocols and close monitoring. The risk factors for intestinal transplant rejection are multifaceted and can be categorized into several key areas.

  • Immunological factors such as HLA mismatching between donor and recipient, pre-existing donor-specific antibodies, and previous sensitization through blood transfusions or pregnancies play a significant role in rejection risk 1.
  • Technical and surgical complications like vascular thrombosis, ischemia-reperfusion injury, and prolonged cold ischemia time significantly increase rejection risk, as highlighted in studies on intestinal transplantation outcomes 1.
  • Patient-related factors including young age, high BMI, and certain underlying diseases (particularly autoimmune disorders) also contribute to higher rejection rates, as noted in guidelines for intestinal transplantation 1.
  • Infections with cytomegalovirus (CMV) or Epstein-Barr virus (EBV) can trigger inflammatory responses that promote rejection, emphasizing the need for prophylactic measures and monitoring 1.
  • Medication non-adherence is a critical risk factor, as inconsistent immunosuppression allows the immune system to mount responses against the graft. The intestine's large lymphoid tissue content and constant exposure to environmental antigens make it particularly susceptible to rejection compared to other organs.
  • Early recognition of these risk factors allows for personalized immunosuppression protocols, typically including tacrolimus, corticosteroids, and antimetabolites like mycophenolate mofetil, with close monitoring of drug levels and regular endoscopic surveillance to detect rejection early 1. Given the complexity and severity of intestinal transplant rejection, managing these risk factors is crucial for improving patient outcomes and reducing morbidity and mortality.

From the Research

Risk Factors for Intestinal Transplant Rejection

The risk factors for intestinal transplant rejection can be categorized into several key areas, including:

  • Acute Rejection Episodes: Studies have shown that acute rejection episodes, particularly those occurring within the first month after transplant, can increase the risk of chronic rejection 2. The severity and frequency of acute rejection episodes are also important factors, with more severe and frequent episodes associated with a higher risk of chronic rejection 3.
  • Recipient Characteristics: Older recipient age, non-Caucasian race, and Caucasian to non-Caucasian transplant have been identified as risk factors for chronic rejection in intestinal transplant patients 2.
  • Donor Characteristics: Donor age and the type of graft (e.g., isolated small bowel vs. small bowel-liver graft) may also influence the risk of chronic rejection 2.
  • Immunosuppression: The level of immunosuppression, including the dose and type of immunosuppressive medications, can impact the risk of rejection. For example, a lower dose of cyclosporine (<5mg/kg/day) has been associated with an increased risk of chronic rejection in kidney transplant patients 4.
  • Infection: Infections, particularly those occurring within the first 6 months after transplant, can increase the risk of rejection. Risk factors for infection include age <18, inclusion of the liver, and pre-transplant bilirubin >5 5.

Key Findings

Some key findings from the studies include:

  • Acute rejection is a significant risk factor for chronic rejection in intestinal transplant patients 2, 4, 3.
  • The severity and frequency of acute rejection episodes can impact the risk of chronic rejection 3.
  • Recipient characteristics, such as age and race, can influence the risk of chronic rejection 2.
  • Donor characteristics, such as age and graft type, may also impact the risk of chronic rejection 2.
  • Infections, particularly those occurring within the first 6 months after transplant, can increase the risk of rejection 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphologic progression.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2003

Research

Six-month incidence of bloodstream infections in intestinal transplant patients.

Transplant infectious disease : an official journal of the Transplantation Society, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.